Dow Down 0.05% Nasdaq Down 0.08%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqCM
2.96 Down 0.01(0.34%) May 23, 4:00PM EDT
Prev Close:2.97
Open:2.92
Bid:2.45 x 1000
Ask:12.74 x 100
1y Target Est:31.17
Beta:3.14393
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:2.86 - 3.07
52wk Range:1.95 - 11.25
Volume:83,710
Avg Vol (3m):169,622
Market Cap:39.47M
P/E (ttm):N/A
EPS (ttm):-0.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTX

Comparison

Symbol% ChgMkt Cap
CYTXDown 0.34%39.47M
BAXDown 0.51%23.58B
OSIRUp 2.17%178.47M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, incl... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback